These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12749209)

  • 21. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S; Higashi T; Nouso K; Kariyama K; Nakamura S; Suzuki M; Nakatsukasa H; Kobayashi Y; Hanafusa T; Tsuji T; Shiratori Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J; Hu J; Cai J
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
    Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of vascular endothelial growth factor (VEGF) concentration in serum of patients with colorectal carcinoma].
    Broll R; Erdmann H; Windhövel U; Duchrow M; Strik MW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):315-8. PubMed ID: 14518267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G; Obermair A; Koschat M; Preyer O; Kotz R; Trieb K
    Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
    van Hensbergen Y; Broxterman HJ; Hanemaaijer R; Jorna AS; van Lent NA; Verheul HM; Pinedo HM; Hoekman K
    Clin Cancer Res; 2002 Dec; 8(12):3747-54. PubMed ID: 12473585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
    Edgren M; Lennernäs B; Larsson A; Kälkner KM
    Anticancer Res; 2001; 21(2B):1423-9. PubMed ID: 11396226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significantly increased concentrations of the angiogenic growth factor bFGF in malignant soft tissue tumors].
    Lehnhardt M; Vogt PM; Wagner D; Steinau HU
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):119-23. PubMed ID: 14518225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy.
    Seko Y; Fukuda S; Nagai R
    Clin Sci (Lond); 2004 May; 106(5):439-42. PubMed ID: 14965340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline.
    Brivio F; Lissoni P; Rovelli F; Nespoli A; Uggeri F; Fumagalli L; Gardani G
    Hepatogastroenterology; 2002; 49(44):385-7. PubMed ID: 11995457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus.
    Malamitsi-Puchner A; Sarandakou A; Tziotis J; Dafogianni C; Bartsocas CS
    Pediatr Res; 1998 Dec; 44(6):873-5. PubMed ID: 9853920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endostatin variations in childhood acute lymphoblastic leukaemia--comparison with basic fibroblast growth factor and vascular endothelial growth factor.
    Schneider P; Vasse M; Corbière C; Legrand E; Marie-Cardine A; Boquet C; Cazin L; Vannier JP
    Leuk Res; 2007 May; 31(5):629-38. PubMed ID: 17011029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
    Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
    Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor is a major mediator in heparin-induced angiogenesis.
    Okada M; Matsumori A; Ono K; Miyamoto T; Takahashi M; Sasayama S
    Biochem Biophys Res Commun; 1999 Feb; 255(1):80-7. PubMed ID: 10082659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum endostatin levels are elevated in patients with soft tissue sarcoma.
    Feldman AL; Pak H; Yang JC; Alexander HR; Libutti SK
    Cancer; 2001 Apr; 91(8):1525-9. PubMed ID: 11301401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors.
    Thomas JP; Arzoomanian RZ; Alberti D; Marnocha R; Lee F; Friedl A; Tutsch K; Dresen A; Geiger P; Pluda J; Fogler W; Schiller JH; Wilding G
    J Clin Oncol; 2003 Jan; 21(2):223-31. PubMed ID: 12525513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endostatin and vascular endothelial cell growth factor (VEGF) in piglet lungs: effect of inhaled nitric oxide and hyperoxia.
    Ekekezie II; Thibeault DW; Rezaiekhaligh MH; Norberg M; Mabry S; Zhang X; Truog WE
    Pediatr Res; 2003 Mar; 53(3):440-6. PubMed ID: 12595592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma.
    Iguchi H; Yokota M; Fukutomi M; Uchimura K; Yonemasu H; Hachitanda Y; Nakao Y; Tanaka Y; Sumii T; Funakoshi A
    J Exp Clin Cancer Res; 2002 Sep; 21(3):309-13. PubMed ID: 12385570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.